- Home
- GATX vs BBIO Comparison
GATX vs BBIO Comparison
Compare GATX & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GATX
- BBIO
- Stock Information
- Founded
- GATX 1898
- BBIO 2015
- Country
- GATX United States
- BBIO United States
- Employees
- GATX N/A
- BBIO N/A
- Industry
- GATX Transportation Services
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GATX Consumer Discretionary
- BBIO Health Care
- Exchange
- GATX Nasdaq
- BBIO Nasdaq
- Market Cap
- GATX 4.9B
- BBIO 5.8B
- IPO Year
- GATX N/A
- BBIO 2019
- Fundamental
- Price
- GATX $139.84
- BBIO $26.27
- Analyst Decision
- GATX Buy
- BBIO Strong Buy
- Analyst Count
- GATX 2
- BBIO 10
- Target Price
- GATX $131.00
- BBIO $47.20
- AVG Volume (30 Days)
- GATX 113.7K
- BBIO 2.5M
- Earning Date
- GATX 10-22-2024
- BBIO 10-31-2024
- Dividend Yield
- GATX 1.67%
- BBIO N/A
- EPS Growth
- GATX 7.66
- BBIO N/A
- EPS
- GATX 6.50
- BBIO N/A
- Revenue
- GATX $1,495,400,000.00
- BBIO $219,124,000.00
- Revenue This Year
- GATX $11.91
- BBIO $4,182.17
- Revenue Next Year
- GATX $5.13
- BBIO N/A
- P/E Ratio
- GATX $21.35
- BBIO N/A
- Revenue Growth
- GATX 12.79
- BBIO 3761.22
- 52 Week Low
- GATX $97.21
- BBIO $21.62
- 52 Week High
- GATX $151.33
- BBIO $44.32
- Technical
- Relative Strength Index (RSI)
- GATX 57.50
- BBIO 44.88
- Support Level
- GATX $129.14
- BBIO $25.92
- Resistance Level
- GATX $139.85
- BBIO $32.06
- Average True Range (ATR)
- GATX 2.66
- BBIO 1.53
- MACD
- GATX 0.22
- BBIO -0.23
- Stochastic Oscillator
- GATX 84.74
- BBIO 20.95
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates four business segments: rail North America, rail international, and portfolio management. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.